Navigation Links
Guiding principles for facial transplantation unveiled

The American Society of Plastic Surgeons (ASPS) and the American Society for Reconstructive Microsurgery (ASRM) today unveiled a landmark joint document, Facial Transplantation-ASPS/ASRM Guiding Principles, to assist plastic surgeons considering participation in facial transplantation procedures.

"This is truly a remarkable and historic time in plastic surgery," said Bruce Cunningham, MD and ASPS president. "The ability to help restore some hope to a person who suffers from severe facial disfigurement for an improved quality of life is a wonderful thing. Still, there are many unanswered questions regarding this challenge and many important considerations for all involved."

The document considers the issue of facial transplantation by examining various subjects including, immunosuppression, transplant rejection, technical issues and psychological aspects (both those facing all transplant patients and those unique to facial transplant patients).

"As plastic surgeons we fully recognize the revolutionary prospects of facial transplantation," said William C. Pederson, MD and president of ASRM. "We just need to make sure that we approach this challenge having reflected on all the possibilities for both the patient and the surgical team."

The document concludes with 10 Guiding Principles that a surgeon should consider before undertaking facial transplantation for a patient. The principles address such issues as: appropriate patient selection; medical facility selection; patient informed consent; patient psychological evaluation; proper institutional oversight; and the ethics of the procedure.


'"/>

Source:American Society of Plastic Surgeons


Page: 1

Related biology news :

1. Plastic surgeons countdown first full facial transplantation
2. Perceived facial similarity in children is an estimate of kin recognition
3. Tissue engineering for craniofacial reconstruction
4. Computer imaging assists with facial reconstructive surgery
5. Monkeying around to improve organ transplantation
6. New cell transplantation technique restores insulin production in diabetics
7. Diabetes researchers pioneer islet cell xenotransplantation in primate studies
8. Successful transplantation from pig embryos to mice
9. Researchers create genetically matched embryonic stem cells for transplantation
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/29/2016)... 29, 2016 BioDirection, a privately held medical ... the objective detection of concussion and other traumatic brain ... completed a meeting with the U.S. Food and Drug ... Pre-Submission Package. During the meeting company representatives reviewed plans ... precursor to commencement of a planned pilot trial. ...
(Date:11/24/2016)... , Nov. 23, 2016 Cercacor today introduced ... and their trainers non-invasively measure hemoglobin, Oxygen ... Rate, and Respiration Rate in approximately 30 seconds. Smaller ... easy and immediate access to key data about their ... a training regimen. Hemoglobin carries oxygen ...
(Date:11/19/2016)... , Nov. 18, 2016 Securus Technologies, ... solutions for public safety, investigation, corrections and monitoring, announced ... smaller competitor, ICSolutions, to have an independent technology judge ... the most modern high tech/sophisticated telephone calling platform, and ... customers that they do most of what we do ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... ... December 08, 2016 , ... Opal Kelly, ... essential device-to-computer interconnect using USB or PCI Express, announced the FOMD-ACV-A4, the company's ... is a small, thin, SODIMM-style module that fits a standard 204-pin SODIMM socket ...
(Date:12/8/2016)... Maryland (PRWEB) , ... December ... ... announces the commercial launch of flexible packaging for their exceptionally efficient ... disposable bag system extends RoosterBio’s portfolio of bioprocess media products engineered to ...
(Date:12/8/2016)... 8, 2016  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), ... and plans to commercialize innovative therapeutics for patients ... stock were approved for trading on the OTCQX ... the OTCQX, effective today, under the ticker symbol ... market, companies must meet high financial standards, follow ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... I/II dose escalation and expansion clinical trial for its lead drug candidate, AC0010, ... purpose of the trial was to determine the safety, antitumor activity, and recommended ...
Breaking Biology Technology: